85 related articles for article (PubMed ID: 20356933)
1. The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission.
Auriemma RS; Galdiero M; De Martino MC; De Leo M; Grasso LF; Vitale P; Cozzolino A; Lombardi G; Colao A; Pivonello R
Eur J Endocrinol; 2010 Jun; 162(6):1035-42. PubMed ID: 20356933
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen concentration is increased in acromegalic women.
Manetti L; Lupi I; Genovesi M; Morselli L; Grasso L; Nencetti C; Gasperi M; Bogazzi F; Bartalena L; Martino E
J Endocrinol Invest; 2004; 27(7):643-7. PubMed ID: 15505987
[TBL] [Abstract][Full Text] [Related]
3. Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs.
Fadini GP; Dassie F; Albiero M; Boscaro E; Albano I; Martini C; de Kreutzenberg SV; Agostini C; Avogaro A; Vettor R; Maffei P
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2549-56. PubMed ID: 25144634
[TBL] [Abstract][Full Text] [Related]
4. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
[TBL] [Abstract][Full Text] [Related]
5. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease.
Davi' MV; Dalle Carbonare L; Giustina A; Ferrari M; Frigo A; Lo Cascio V; Francia G
Eur J Endocrinol; 2008 Nov; 159(5):533-40. PubMed ID: 18765561
[TBL] [Abstract][Full Text] [Related]
6. Cardiac effect of thyrotoxicosis in acromegaly.
Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients.
Bogazzi F; Ultimieri F; Raggi F; Costa A; Gasperi M; Cecconi E; Mosca F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2002 May; 87(5):2403-6. PubMed ID: 11994396
[TBL] [Abstract][Full Text] [Related]
8. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
10. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
[TBL] [Abstract][Full Text] [Related]
11. Clinical and metabolic characteristics of acromegalic patients with high IGF1/normal GH levels during somatostatin analog treatment.
Matta M; Bongard V; Grunenwald S; Maiza JC; Bennet A; Caron P
Eur J Endocrinol; 2011 Jun; 164(6):885-9. PubMed ID: 21471168
[TBL] [Abstract][Full Text] [Related]
12. Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery.
Rubeck KZ; Madsen M; Andreasen CM; Fisker S; Frystyk J; Jørgensen JO
Eur J Endocrinol; 2010 Nov; 163(5):717-26. PubMed ID: 20813787
[TBL] [Abstract][Full Text] [Related]
13. Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Farrerons J; Lluch P; Puig T; Wägner AM; Ricart W; Webb SM
Eur J Endocrinol; 2008 Dec; 159(6):773-9. PubMed ID: 18805912
[TBL] [Abstract][Full Text] [Related]
14. Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors.
Ronchi CL; Varca V; Beck-Peccoz P; Orsi E; Donadio F; Baccarelli A; Giavoli C; Ferrante E; Lania A; Spada A; Arosio M
J Clin Endocrinol Metab; 2006 Jan; 91(1):121-8. PubMed ID: 16263816
[TBL] [Abstract][Full Text] [Related]
15. Renal handling of iodothyronines in acromegaly.
Eskildsen PC; Faber J; Siersbaek-Nielsen K
Scand J Clin Lab Invest; 1987 Feb; 47(1):17-21. PubMed ID: 3576106
[TBL] [Abstract][Full Text] [Related]
16. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
[TBL] [Abstract][Full Text] [Related]
17. Treatable glomerular hyperfiltration in patients with active acromegaly.
Fujio S; Takano K; Arimura H; Habu M; Bohara M; Hirano H; Hanaya R; Nishio Y; Koriyama C; Kinoshita Y; Arita K
Eur J Endocrinol; 2016 Oct; 175(4):325-33. PubMed ID: 27440194
[TBL] [Abstract][Full Text] [Related]
18. Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates.
Losa M; Mortini P; Urbaz L; Ribotto P; Castrignanó T; Giovanelli M
J Neurosurg; 2006 Jun; 104(6):899-906. PubMed ID: 16776333
[TBL] [Abstract][Full Text] [Related]
19. Prostatic disorders in acromegalic patients experience of a Brazilian center.
Corrêa LL; Balarini Lima GA; Cavallieri SA; Miranda LC; Gadelha MR
Int Braz J Urol; 2013; 39(3):393-401. PubMed ID: 23849571
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly.
Selvarajah D; Webster J; Ross R; Newell-Price J
Eur J Endocrinol; 2005 Apr; 152(4):569-74. PubMed ID: 15817912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
